MENU

USA: Do mobile messages about HPV work?

14 Oct, 2018
, Source:

Most college students regularly use a smartphone, and these days there’s a mobile app for just about anything. That’s why health promoters, health communicators and health care providers have been exploring the possibilities of mHealth technologies to educate consumers about health care services.

New research from the University of Georgia suggests that in the case of HPV, health care providers shouldn’t place too much faith in the smart device alone to get their message across.

“Although college students own, utilize and speak technology more than any other population subgroup, this study indicates that college students are overwhelmingly hesitant to receive basic information about the HPV virus and vaccine over their smartphone,” said Gabrielle Darville, a health promotion and behavior researcher at UGA’s College of Public Health and lead author on the study.

Human papillomavirus, or HPV, is the most common sexually transmitted infection, currently affecting more than 79 million people in the United States. Though a vaccine has been available for 10 years, many college students did not receive the HPV vaccine as adolescents.

As health promoters, Darville said, “our goal is to close the gap in any HPV vaccine disparities among these young adults especially before the [health insurance] cutoff age of 26 to receive the vaccine.”

The study surveyed 210 students, aged 18 to 25, about their preferences using mobile health apps or texts to receive information about HPV and the HPV vaccine. Overall, respondents were hesitant to use texts and apps for HPV due to privacy, memory and data cost concerns. Their responses were also categorized by gender, age and health insurance type so the researchers could learn whether these factors further impact HPV knowledge and communication preferences.

Women, students with private health insurance, and those with easier access to a doctor tended to prefer getting information directly from a health care provider. Men, however, were more likely to learn about HPV vaccines from a mobile app.

“What the results tell us is that we should tailor and customize our mHealth interventions when working with the collegiate population, said Darville.

According to Darville, these findings show that the traditional “one-size-fits-all” strategy of providing general information through an app may only have limited success.

“I think to overcome the concerns, public health and health care professionals should take more time to explore the way the message is framed and the intervention is packaged over mHealth technologies,” she said. “By understanding those individual differences and integrating them into our strategies, only then can we increase HPV knowledge, encourage positive beliefs/ attitudes and empower those in the “catch-up” group to complete the three-dose vaccine series by the cutoff age of 26.”

The study, “Utilizing mHealth technology to increase HPV knowledge and HPV vaccine uptake in adolescents: A qualitative study,” appeared in the Journal of Adolescent and Family Health. It is available online here: https://scholar.utc.edu/jafh/vol9/iss1/9/

Co-authors include Charkarra Anderson-Lewis, Rebeccah Mercado, Jessica Ma and Jann MacInnes.

This entry was posted on Sunday, October 14th, 2018 at 8:32 am and is filed under Latest News.

Literature Literature archive

Baalen, S. van. 2018 Research Ethics 14(4), 1–17. https://doi.org/10.1177/1747016117750312

Videos Video archive

Key figures share their perspectives on a controversy that led to the suspension of Ebola vaccine clinical trials in Ghana.

Drs. Heidi Larson and Pauline Paterson of the Vaccine Confidence Project join episode 50 of the Public Health United podcast with Nina Martin, November 2017.

Drs. Larson and Paterson join a discussion on vaccine confidence at Hong Kong University.  September, 2015.

Subscribe to our mailing list

Click here to go to our GDPR-compliant signup form.

  • Recent Posts